Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Hyponatremia risk may differ across second-generation antipsychotics

Antipsychotics are used to treat schizophrenia, along with bipolar disorder and major depressive disorder. However, these medications can be associated with hyponatremia, a serious reduction in blood sodium levels.

Hyponatremia risk may differ across second-generation antipsychotics

An analysis of hyponatremia risk associated with second-generation antipsychotic medications revealed potential differences among individual drugs. Associate Professor Masakazu Hatano and colleagues from Fujita Health University School of Medicine in Japan conducted a two-part study, first using FDA Adverse Event Reporting System data to generate hypotheses regarding hyponatremia risk, then evaluating these hypotheses using Japanese hospital-based claims data.

The U.S. safety reporting analysis included 17.8 million reports, of which 458,745 involved second-generation antipsychotic monotherapy. Several drugs showed lower reporting odds for hyponatremia than olanzapine, the reference antipsychotic, with brexpiprazole and lurasidone showing the lowest reporting odds. However, these findings were hypothesis-generating due to limitations in the spontaneous reporting data.

The Japanese claims database analysis included 55,394 patients prescribed antipsychotics, followed for up to 180 days. During follow-up, hyponatremia occurred in 366 patients (0.7%). After adjusting for differences in baseline characteristics and other factors, aripiprazole was associated with a significantly lower risk of hyponatremia compared to olanzapine, while other second-generation antipsychotics showed no significant differences.

These findings suggest that the risk of hyponatremia may vary among individual second-generation antipsychotics, potentially guiding treatment decisions for patients at higher risk. However, the study's observational nature means residual confounding and differences in hyponatremia detection may have influenced the results.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Thursday 8 October →